Diametrics Neurotrend
This article was originally published in The Gray Sheet
Executive Summary
Multiparameter system for continuously monitoring oxygen, carbon dioxide, acidity and temperature in the brain gains FDA market go-ahead and will be distributed by Johnson & Johnson subsidiary Codman under an October 1998 exclusive worldwide agreement. The firm simultaneously announces FDA clearance of a stand-alone calibration system for use with both the Neurotrend and Trendcare monitoring systems